Table 1:
Characteristic | Control (n = 5)* | Sleep-Deprived (n=5)* |
---|---|---|
Age, years | ||
Sex, M/F | 2/3 | 2/3 |
Race, C/AA | 2/3 | 2/3 |
MMSE | ||
CSF Aβ42/40 at hour 0 | ||
Plasma Aβ42/40 at hour 0 | ||
SSS on Day of Catheter Placement | ||
Overnight TST (min) | ||
Overnight SE (%) |
AA = African American; C = Caucasian; F = female; M = male; MMSE = Mini-Mental State Examination; CSF = cerebrospinal fluid; Aβ = amyloid-β; SSS = Stanford Sleepiness Scale; TST = total sleep time; SE = sleep efficiency; SD = standard deviation.
5 participants completed both the sleep-deprived and normal sleep groups with interventions 4–6 months apart; all assessments were completed for each intervention group.